IP Library › Granted Patent US 11,219,709
Granted Patent B2
US 11,219,709 · App. 16/214,728 · Granted Jan 11, 2022

Systems and methods for treating blood

Inventors: Patrick Richard Spearman (The Woodlands, TX); Shelly Amann (West Saint Paul, MN)
Assignee: HUMANITY LIFE EXTENSION LLC
A61M1/369A61M1/3653A61M1/3633A61M1/3663A61M2205/366
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,219,709
App. No.
16/214,728
Granted
Jan 11, 2022
Kind
B2
Abstract

According to some embodiments, a system may treat blood containing metformin outside the body of a patient. The system may include one or more pumps configured to pump blood in a fluid flow path at a collective rate over 4 liters per minute. The system may include one or more heat exchangers operable to heat at least a portion of the blood to a temperature of at least 42 degrees. The system may include one or more convection dialysis modules configured to perform convection dialysis on at least a portion of the blood at least after the one or more heat exchangers allow the blood to cool one or more degrees.

Claims (103)

1. A system comprising:

blood containing metformin;

one or more pumps configured to pump blood in a fluid flow path at a collective rate between 4 and 7 liters per minute;

one or more convection dialysis modules coupled to the fluid flow path and configured to perform dialysis on at least a portion of the blood, the one or more convection dialysis modules configured to remove substances from the blood that are over 6000 Daltons in size; and

one or more heat exchangers coupled to the fluid flow path and configured to heat at least a portion of the blood to a temperature of between 42 and 45 degrees Celsius, wherein the blood was received from a patient undergoing a hyperthermia treatment and with a core body temperature, as measured inside of the bladder, of between 42 and 43.2 degrees Celsius, and wherein the patient receives metformin only in connection with the hyperthermia treatment.

2. The system of claim 1 , wherein the one or more heat exchangers are configured to heat the blood to a temperature between 42.5 and 45 degrees Celsius.

3. The system of claim 1 , wherein the one or more heat exchangers are configured to heat the blood to a temperature between 42 and 44.5 degrees Celsius.

4. The system of claim 1 , wherein the one or more heat exchangers are configured to heat the blood to a temperature of between 42.5 and 44.5 degrees Celsius.

5. The system of claim 1 , further comprising a reintroduction module coupled to the fluid flow path and configured to add a substance to at least a portion of the blood, the substance facilitating the production of reactive oxygen species within the blood.

6. The system of claim 5 wherein the substance comprises at least one of iron, copper, and ozone.

7. The system of claim 5 , wherein the substance comprises iron.

8. The system of claim 1 , further comprising one or more venting modules coupled to the fluid flow path and configured to:

remove carbon dioxide from at least a portion of the blood; and

add oxygen to at least a portion of the blood.

9. The system of claim 1 , wherein the one or more convection dialysis modules coupled to the fluid flow path are configured to:

perform dialysis on at least a portion of the blood at a collective rate of between 0.9 and 3 liters per minute; and

remove substances from the blood that are at least 6000 Daltons in size.

10. The system of claim 1 , wherein

the one or more convection dialysis modules coupled to the fluid flow path are configured to perform dialysis on at least a portion of the blood at a collective rate of between 0.9 and 3 liters per minute; and

the one or more heat exchangers are configured to heat the blood to a temperature between 42.5 and 45 degrees Celsius; and

further comprising:

a reintroduction module coupled to the fluid flow path and configured to add a substance to at least a portion of the blood, the substance facilitating the production of reactive oxygen species within the blood; and

one or more venting modules coupled to the fluid flow path and configured to:

remove carbon dioxide from at least a portion of the blood; and

add oxygen to at least a portion of the blood.

11. A method comprising:

pumping blood containing metformin in a fluid flow path at a rate between 4 and 7 liters per minute;

performing convection dialysis on at least a portion of the blood, the convection dialysis removing substances from the blood that are at least 6000 Daltons in size; and

heating at least a portion of the blood to a temperature of between 42 and 45 degrees Celsius, wherein the blood was received from a patient undergoing a hyperthermia treatment and with a core body temperature, as measured inside of the bladder, of between 42 and 43.2 degrees Celsius, and wherein the patient receives metformin only in connection with the hyperthermia treatment.

12. The method of claim 11 , wherein at least a portion of the blood is heated to a temperature between 42.5 and 44.5 degrees.

13. The method of claim 12 , wherein heating of the blood causes a patient's body temperature to be between 42 and 44.5 degrees for between 30 minutes and 6 hours.

14. The method of claim 11 , wherein the blood is pumped at a rate of between 5 and 7 liters per minute.

15. The method of claim 11 , wherein the blood is pumped at a rate between 4 and 6 liters per minute.

16. The method of claim 11 , further comprising adding a substance to at least a portion of the blood in the fluid flow path, the substance facilitating the production of reactive oxygen species within the blood.

17. The method of claim 16 , wherein the substance comprises at least one of: iron, copper, and ozone.

18. The method of claim 16 , wherein the substance comprises iron.

19. The method of claim 11 , further comprising adding a chemotherapeutic substance to at least a portion of the blood.

20. The method of claim 11 , further comprising removing carbon dioxide from at least a portion of the blood.

21. The method of claim 20 , wherein carbon dioxide is removed from at least a portion of the blood substantially continuously for a period of between 30 minutes and 6 hours.

22. The method of claim 11 , wherein performing convection dialysis on at least a portion of the blood comprises performing convection dialysis at a rate between 0.9 and 3 liters per minute.

23. The method of claim 22 , further comprising adding electrolyte balanced fluid to at least a portion of the blood at a rate between 7 and 30 liters per hour.

24. The method of claim 23 , wherein the electrolyte balanced fluid is added to at least a portion of the blood at a rate between 7 and 30 liters per hour for between 30 minutes and 6 hours.

25. The method of claim 11 , wherein the blood is pumped in the fluid flow path at the rate of between 4 and 7 liters per minute for between 30 minutes and 6 hours.

26. The method of claim 25 , wherein the blood is pumped in the fluid flow path at the rate of between 4 and 7 liters per minute substantially continuously for between 30 minutes and 6 hours.

27. The method of claim 11 , wherein the convection dialysis is performed on at least a portion of the blood at the rate of between 0.9 and 3 liters per minute for between 30 minutes and 48 hours.

28. The method of claim 23 , wherein the convection dialysis is performed on at least a portion of the blood substantially continuously at the rate of between 0.9 and 3 liters per minute for between 30 minutes and 48 hours.

29. The method of claim 11 , wherein the blood is heated to a temperature of between 42 and 45 degrees Celsius for between 30 minutes and 6 hours.

30. The method of claim 11 , wherein the blood is heated to a temperature of between 42 and 45 degrees Celsius substantially continuously for between 30 minutes and 6 hours.

31. The method of claim 11 , wherein performing convection dialysis comprises:

performing convection dialysis on at least a portion of the blood at a rate of between 0.9 and 3 liters per minute; and

removing substances from the blood that are at least 6000 Daltons in size.

32. The method of claim 11 , wherein the convection dialysis is performed on at least a portion of the blood at the rate of between 0.9 and 3 liters per minute; and

the blood is heated to a temperature between 42.5 and 45 degrees Celsius; and

further comprising:

adding a substance to at least a portion of the blood, the substance facilitating the production of reactive oxygen species within the blood;

removing carbon dioxide from at least a portion of the blood; and

adding oxygen to at least a portion of the blood.

33. The method of claim 32 wherein the substance is iron.

34. The method of claim 32 , further comprising performing albumin dialysis on at least a portion of the blood.

35. A method for treating cancer comprising:

providing a human body with a dose of Metformin such that blood of the human body contains Metformin wherein the patient receives the dose of Metformin only in connection with a hyperthermia treatment of the human body;

removing at least some of the blood from the human body into a fluid flow path at a rate of between 4 and 7 liters per minute;

heating at least some of the blood outside of the human body;

performing convection dialysis on at least a portion of the blood outside of the human body, the convection dialysis removing substances from the blood that are at least 6000 Daltons in size;

returning at least some of the blood to the human body after heating the blood outside of the human body; and

wherein the human body is heated to a core temperature of between 42 and 43.2 degrees Celsius for between 30 minutes and 6 hours while undergoing the hyperthermia treatment.

36. The method of claim 35 , wherein the dose of Metformin is provided prior to heating the human body to a core temperature of between 42 and 45 degrees Celsius.

37. The method of claim 35 , wherein the dose of Metformin is provided during the heating of the human body to a core temperature of between 42 and 45 degrees Celsius.

38. The method of claim 35 , further comprising causing the production of reactive oxygen species within the human body by adding a substance to at least a portion of the blood.

39. The method of claim 38 wherein the substance comprises at least one of: iron, copper, Freon, and ozone.

40. The method of claim 38 wherein the substance comprises iron.

41. The method of claim 35 further comprising removing carbon dioxide from at least a portion of the blood outside of the human body.

42. The method of claim 41 , wherein carbon dioxide is removed from at least a portion of the blood for between 30 minutes and 6 hours.

43. The method of claim 35 , wherein performing convection dialysis on at least a portion of the blood comprises performing convection dialysis at a rate between 0.9 and 3 liters per minute.

44. The method of claim 43 , further comprising adding electrolyte balanced fluid to the human body at a rate between 7 and 30 liters per hour.

45. The method of claim 44 , wherein the electrolyte-balanced fluid is added to the human body at a rate between 7 and 30 liters per hour for between 30 minutes and 6 hours.

46. The method of claim 45 , wherein carbon dioxide is removed from at least a portion of the blood substantially continuously for between 30 minutes and 6 hours.

47. The method of claim 43 wherein the convection dialysis is performed on at least a portion of the blood at the rate of between 0.9 and 3 liters per minutes for between 30 minutes and 48 hours.

48. The method of claim 47 , herein the convection dialysis is performed on at least a portion of the blood at the rate of between 0.9 and 3 liters per minutes substantially continuously for between 30 minutes and 48 hours.

49. The method of claim 35 , further comprising pumping the blood in the fluid flow path at a rate between 4 and 7 liters per minute for between 30 minutes and 6 hours.

50. The method of claim 49 , wherein the blood is pumped in the fluid flow path at a rate between 4 and 7 liters per minute substantially continuously for between 30 minutes and 6 hours.

51. The method of claim 50 , wherein the electrolyte balanced fluid is added to the human body at a rate between 7 and 30 liters per hour substantially continuously for between 30 minutes and 6 hours.

52. The method of claim 35 , where in the human body is heated to the temperature of between 42 and 45 degrees Celsius substantially continuously for between 30 minutes and 6 hours.

53. A method for treating cancer comprising:

providing a human body with a dose of Metformin such that blood of the human body contains Metformin wherein the patient receives the dose of Metformin only in connection with a hyperthermia treatment of the human body;

providing the human body with a dose of iron such that the blood of the human body contains increased amounts of iron as compared to before receiving the dose of iron;

removing blood from the human body into a fluid flow path at a rate of between 4 and 7 liters per minute;

heating at least some of the blood outside of the human body;

returning at least some of the blood to the human body after heating the blood outside of the human body; and

wherein the human body is heated to a core temperature of between 42 and 43.2 degrees Celsius for between 30 minutes and 6 hours while undergoing the hyperthermia treatment.

54. The method of claim 53 , wherein the dose of Metformin is provided prior to heating the human body to a core temperature of between 42 and 45 degrees Celsius.

55. The method of claim 53 , wherein the dose of Metformin is provided during the heating of the human body to a core temperature of between 42 and 45 degrees Celsius.

56. The method of claim 53 further comprising removing carbon dioxide from at least a portion of the blood outside of the human body.

57. The method of claim 56 , wherein carbon dioxide is removed from at least a portion of the blood for between 30 minutes and 6 hours.

58. The method of claim 53 , further comprising performing convection dialysis on at least a portion of the blood at a rate between 0.9 and 3 liters per minute.

59. The method of claim 53 , further comprising adding electrolyte balanced fluid to the human body at a rate between 7 and 30 liters per hour.

60. The method of claim 59 , wherein the electrolyte-balanced fluid is added to the human body at a rate between 7 and 30 liters per hour for between 30 minutes and 6 hours.

61. The method of claim 60 , further comprising removing carbon dioxide from at least a portion of the blood substantially continuously for between 30 minutes and 6 hours.

62. The method of claim 61 further comprising performing convection dialysis on at least a portion of the blood at the rate of between 0.9 and 3 liters per minutes for between 30 minutes and 48 hours.

63. The method of claim 61 , further comprising performing convection dialysis on at least a portion of the blood at the rate of between 0.9 and 3 liters per minutes substantially continuously for between 30 minutes and 48 hours.

64. The method of claim 61 , further comprising pumping the blood in the fluid flow path at a rate between 4 and 7 liters per minute for between 30 minutes and 6 hours.

65. The method of claim 61 , wherein the blood is pumped in the fluid flow path at a rate between 4 and 7 liters per minute substantially continuously between 30 minutes and 6 hours.

66. The method of claim 61 , where in the human body is heated to the temperature of between 42 and 45 degrees Celsius substantially continuously for between 30 minutes and 6 hours.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2018
From: SPEARMAN, PATRICK RICHARD; AMANN, SHELLY
To: HUMANITY LIFE EXTENSION LLC
Reel/Frame 047728/0290 →
Continuity (1)
Related Publication 20200179586A1 · Jun 11, 2020
Cited By (1)
US 12,246,123